Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer

Title
Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume -, Issue -, Pages -
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2018-09-25
DOI
10.1056/nejmoa1810171

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started